Cytoskeletal processing in sublethal brain injury
Cytoskeletal processing in sublethal brain injury
批准号:
6740731
负责人:
JON S MORROW
金额:
$29.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-02-01 至 2008-01-31
关键词:
brain injury calpain cerebral ischemia /hypoxia chemical cleavage cysteine endopeptidases cytoskeleton genetically modified animals immunocytochemistry laboratory mouse neuropathology phosphorylation protein structure function proteolysis spectrin staurosporine synaptogenesis tissue /cell culture transfection tyrosine
中文摘要
描述(由申请人提供):
新生儿的大脑对亚致死性缺氧损伤异常敏感。作为一种常见的
伴随着极早产,亚致死性缺氧期扰乱突触
新生儿大脑的重塑和成熟,从而可能解释长期的
这类儿童的认知缺陷。促进突触组织的一种机制
而功能就是神经元的幽灵骨架。最近的数据显示,特定的亚型
在轴突运输、受体运输和受体运输中发挥不同的作用
组织和受体的周转。总的来说,这些活动对神经元和
突触功能。由于血影蛋白骨架受钙信号通路的调节
参与钙调蛋白和钙蛋白酶的蛋白分解,以及丝氨酸和钙蛋白酶的磷酸化。
通过最近发现的酪氨酸磷酸化,我们假设这是不合适的
轻度缺氧性损伤后神经元血影蛋白骨架的修饰有助于
早产儿脑功能障碍的病理学。因此很重要的一点是要理解生理学
钙激活的蛋白水解酶介导的血影蛋白加工的病理后果
发育中的大脑。我们将使用体外分析来确定特定的Calain裂解位点
在BetaI、BetaIII和BetaIV中,并确定这些血影蛋白对钙蛋白酶的敏感性是否与血影蛋白切割变构偶联(与BetaII血影蛋白切割一样)。这些
最近才在专门的神经元中发现了其他的β-血影蛋白亚型。
它们对蛋白质分解的敏感性尚不清楚,生物学上也是如此
这种乳沟的后果。使用切割特异性抗体,地形和
在经历轻度亚致死性缺氧的小鼠中,将使用wt小鼠和动物进行评估,通过使用cre-loxP重组酶系统选择性地删除血影蛋白基因的外显子28-30,来评估体内对这些血影蛋白和alphaII血影蛋白的瞬时处理。这些外显子编码高度敏感的钙蛋白和半胱氨酸天冬氨酸氨基转移酶3靶点,两个假定的酪氨酸磷酸化位点,以及αII血影蛋白的钙调蛋白结合域。因此,这个关键的血影蛋白中心区域是大脑中钙离子和磷酸化介导的信号通路的交汇点。通过产生这些行为中的每一个都被选择性地阻断的动物,将确定这些途径对神经元成熟和存活的贡献。项目核心资源将用于评估这些表型。
英文摘要
DESCRIPTION (provided by applicant):
The neonatal brain is unusually sensitive to sublethal hypoxic injury. As a common
accompaniment of extremely premature birth, periods of sublethal hypoxia disrupt synaptic
remodeling and maturation in the newborn brain, and may thereby account for the long-term
cognitive deficiencies of such children. One mechanism contributing to synaptic organization
and function is the neuronal spectrin skeleton. Recent data has revealed that specific isoforms
of spectrin subserve distinct roles in axonal transport, receptor trafficking, and receptor
organization and receptor turnover. Collectively these activities are crucial to neuronal and
synaptic function. Since the spectrin skeleton is regulated by calcium signaling pathways
involving calmodulin and calpain proteolysis, as well as by phosphorylation on both ser and
thru and by a recently recognized tyrosine phosphorylation, we hypothesize that inappropriate
modification of the neuronal spectrin skeleton following mild hypoxic injury contributes to the
pathology of premature brain dysfunction. It is important to thus understand the physiologic
and pathologic consequences of calcium activated protease-mediated spectrin processing in
the developing brain. We will use in vitro analysis to identify the specific calpain cleavage sites
in betaI, betaIII, and betaIV spectrin, and determine whether the susceptibility of these spectrins to calpain is allosterically coupled to spectrin cleavage (as is betaII spectrin cleavage). These
additional beta-spectrin isoforms have only recently been identified in specialized neuronal
compartments, and their susceptibility to proteolysis is unknown, as is the biologic
consequences of such cleavage. Using cleavage-specific antibodies, the topographic and
temporal in vivo processing of these spectrins and of alphaII spectrin by calpain will be assessed in mice experiencing mild sublethal hypoxia, using both wt mice and animals genetically modified such that exons 28-30 of the spectrin gene have been selectively deleted using the cre-loxp recombinase system. These exons encode the hypersensitive calpain and caspase 3 target sites, two putative sites of tyrosine phosphorylation, and the calmodulin binding domain of alphaII spectrin. This critical central region of spectrin thus serves as a point of convergence between Ca ++ and phosphorylation-mediated signaling pathways in the brain. By generating animals in which each of these actions has been selectively blocked, the contributions of these pathways to neuronal maturation and viability will be determined. Project Core resources will be used to evaluate these phenotypes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2007 Red Cells Gordon Research Conference
-
批准号:7328473
-
项目类别:
-
资助金额:$1.75万
-
财政年份:2007
-
负责人:JON S MORROW
-
依托单位:
Topographic Gene Expression in Developing Brain
-
批准号:6368584
-
项目类别:
-
资助金额:$20.44万
-
财政年份:2001
-
负责人:JON S MORROW
-
依托单位:
Topographic Gene Expression in Developing Brain
-
批准号:6530021
-
项目类别:
-
资助金额:$20.44万
-
财政年份:2001
-
负责人:JON S MORROW
-
依托单位:
DYNAMIC ORGANIZATION OF THE RENAL CELL MEMBRANE SKELETON IN VIVO
-
批准号:6564379
-
项目类别:
-
资助金额:$14.1万
-
财政年份:2001
-
负责人:JON S MORROW
-
依托单位:
CYTOSKELETAL PROCESSING AND SUBLETHAL BRAIN INJURY
-
批准号:6455821
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2001
-
负责人:JON S MORROW
-
依托单位:
CYTOSKELETAL PROCESSING AND SUBLETHAL BRAIN INJURY
-
批准号:6314158
-
项目类别:
-
资助金额:$26.65万
-
财政年份:2000
-
负责人:JON S MORROW
-
依托单位:
DYNAMIC ORGANIZATION OF THE RENAL CELL MEMBRANE SKELETON IN VIVO
-
批准号:6410368
-
项目类别:
-
资助金额:$14.1万
-
财政年份:2000
-
负责人:JON S MORROW
-
依托单位:
CYTOSKELETAL PROCESSING AND SUBLETHAL BRAIN INJURY
-
批准号:6355620
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2000
-
负责人:JON S MORROW
-
依托单位:
DYNAMIC ORGANIZATION OF THE RENAL CELL MEMBRANE SKELETON IN VIVO
-
批准号:6105918
-
项目类别:
-
资助金额:$18.46万
-
财政年份:1999
-
负责人:JON S MORROW
-
依托单位:
CYTOSKELETAL PROCESSING AND SUBLETHAL BRAIN INJURY
-
批准号:6112602
-
项目类别:
-
资助金额:$26.65万
-
财政年份:1999
-
负责人:JON S MORROW
-
依托单位:
CELL AND MOLECULAR PATHOBIOLOGY OF RENAL DISEASE
-
批准号:6124713
-
项目类别:
-
资助金额:$114.03万
-
财政年份:1999
-
负责人:JON S MORROW
-
依托单位:
CELL AND MOLECULAR PATHOBIOLOGY OF RENAL DISEASE
-
批准号:6476230
-
项目类别:
-
资助金额:$96.56万
-
财政年份:1999
-
负责人:JON S MORROW
-
依托单位:
CELL AND MOLECULAR PATHOBIOLOGY OF RENAL DISEASE
-
批准号:2775352
-
项目类别:
-
资助金额:$110.73万
-
财政年份:1999
-
负责人:JON S MORROW
-
依托单位:
CELL AND MOLECULAR PATHOBIOLOGY OF RENAL DISEASE
-
批准号:6329433
-
项目类别:
-
资助金额:$117.2万
-
财政年份:1999
-
负责人:JON S MORROW
-
依托单位:
CELL AND MOLECULAR PATHOBIOLOGY OF RENAL DISEASE
-
批准号:6624902
-
项目类别:
-
资助金额:$123.05万
-
财政年份:1999
-
负责人:JON S MORROW
-
依托单位:
CELL AND MOLECULAR PATHOBIOLOGY OF RENAL DISEASE
-
批准号:6840780
-
项目类别:
-
资助金额:$36.71万
-
财政年份:1999
-
负责人:JON S MORROW
-
依托单位:
DYNAMIC ORGANIZATION OF THE RENAL CELL MEMBRANE SKELETON IN VIVO
-
批准号:6301221
-
项目类别:
-
资助金额:$18.46万
-
财政年份:1999
-
负责人:JON S MORROW
-
依托单位:
CYTOSKELETAL PROCESSING AND SUBLETHAL BRAIN INJURY
-
批准号:6273914
-
项目类别:
-
资助金额:$24.54万
-
财政年份:1998
-
负责人:JON S MORROW
-
依托单位:
DYNAMIC ORGANIZATION OF THE RENAL CELL MEMBRANE SKELETON IN VIVO
-
批准号:6105377
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:JON S MORROW
-
依托单位:
CELL AND MOLECULAR PATHOBIOLOGY OF RENAL DISEASE
-
批准号:2834054
-
项目类别:
-
资助金额:$29.5万
-
财政年份:1998
-
负责人:JON S MORROW
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Wnt5a/Calpain6/Rac1通路激活毛囊黑素干细胞逆转毛发白化的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:星懿展
-
依托单位:
矢车菊素-3-O-葡萄糖苷通过miR-137-3p抑制Calpain-2/β-catenin通路降低胶质瘤细胞干性的信号机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
Calpain活化在线粒体稳态失衡引起噪声性耳蜗损伤中的作用机制
-
批准号:82330034
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:殷善开
-
依托单位:
Calpain/P-eIF2α动态平衡在黄芪甲苷IV治疗顺铂肾损伤中的机制研究
-
批准号:82360738
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:寇温
-
依托单位:
Calpain通过MYC-DHODH促进铁死亡介导早期心肌损伤在病毒性心肌炎中的作用及机制研究
-
批准号:82370361
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈瑞珍
-
依托单位:
热休克蛋白90对calpain-1的变构调节机制及其对鸡肉嫩度的影响
-
批准号:32372406
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:张牧焓
-
依托单位:
靶向抑制线粒体calpain截切ATP5A1蛋白在防治心力衰竭中的关键作用和机制研究
-
批准号:82370388
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:曹婷
-
依托单位:
Calpain调节Kupffer细胞内质网应激介导NLRP3活化促进肝纤维化的机制研究
-
批准号:2023JJ40913
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:杨慧
-
依托单位:
Calpain调控KCC2通路在脑损伤后海马认知功能障碍中的作用及机制
-
批准号:LY23H090012
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:洪远
-
依托单位:
机械敏感离子通道Piezo1通过Ca2+/Calpain途径对类风湿关节炎成纤维样滑膜细胞迁移侵袭的调控和机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:陈冬莹
-
依托单位: